News
7h
The Print on MSNMounjaro, Wegovy signal ashift in obesity care model in India which sees 20k bariatric surgeries a yearIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
You were never warned your biology would change overnight… but today, science shows there's a faster, easier way to get back in shape at any age.
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
We're covering the myriad ways GLP-1 weight loss drugs are changing people's lives. (Photo illustration: Yahoo News; photos: ...
Prof Price added: “We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms.
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.
(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results